What is Melilotus officinalis used for?

Melilotus officinalis is traditionally used to relieve symptoms of chronic venous insufficiency, including leg heaviness, swelling, and mild varicose vein discomfort. The EMA recognizes its traditional use for these indications based on at least 30 years of documented European phytomedicinal use, though clinical trial data remain limited.

Does Melilotus officinalis interact with blood thinners?

Yes, Melilotus officinalis poses a significant interaction risk with anticoagulants such as warfarin and heparin. If the dried herb is improperly stored and undergoes fungal fermentation, coumarin converts to dicoumarol, a potent natural anticoagulant that can potentiate bleeding when combined with pharmaceutical blood thinners. Patients on anticoagulation therapy should avoid this herb entirely.

How much coumarin is in Melilotus officinalis?

Dried Melilotus officinalis aerial parts typically contain 0.4–0.9% coumarin (1,2-benzopyrone) by dry weight, along with its glycoside precursor melilotoside. The EMA recommends oral preparations delivering no more than 1 mg of coumarin per daily dose to minimize hepatotoxicity risk while retaining therapeutic benefit.

Is Melilotus officinalis safe during pregnancy?

Melilotus officinalis is not recommended during pregnancy or breastfeeding due to insufficient safety data in these populations. The coumarin content raises theoretical concerns about fetal exposure, and the EMA explicitly excludes pregnant and lactating women from its traditional-use indication. Women who are pregnant should consult a healthcare provider before using any sweet clover supplement.

What is the difference between Melilotus officinalis and Melilotus albus?

Melilotus officinalis (yellow sweet clover) and Melilotus albus (white sweet clover) are closely related species with similar coumarin content and phytochemical profiles, but Melilotus officinalis is the species specifically covered under the EMA monograph for medicinal use. Melilotus albus has historically been used interchangeably in folk medicine but lacks its own formal regulatory recognition, and its coumarin-to-melilotoside ratio can differ slightly by growth conditions and harvest time.

What is the recommended daily dosage of Melilotus officinalis?

Traditional use studies and EMA monographs typically recommend 300–600 mg of Melilotus officinalis extract daily, often divided into 2–3 doses, though exact dosing varies by extract standardization and product formulation. Dosage should be based on the coumarin content and clinical context, as higher doses may increase anticoagulant effects. Always follow product labeling or consult a healthcare provider for personalized dosing, particularly if taking concurrent medications.

Is Melilotus officinalis safe for elderly people or children?

Safety data in children is lacking, and Melilotus officinalis is generally not recommended for pediatric use without medical supervision due to coumarin content and potential drug interaction risks. In elderly populations, it may be used but requires careful monitoring, especially those on anticoagulants or with bleeding disorders, as age-related changes in metabolism can increase coumarin sensitivity. Medical consultation is advised before use in either population.

What does the clinical evidence actually show about Melilotus officinalis effectiveness?

The EMA classifies Melilotus officinalis as traditional use only, meaning efficacy claims rest on historical use rather than robust randomized controlled trials; no modern clinical studies definitively prove its benefits for venous insufficiency or leg heaviness. Most claims are based on traditional herbal medicine practices and in vitro mechanism studies of coumarin, not human clinical outcomes. Stronger evidence would require well-designed RCTs to validate traditional use assertions.

Melilotus officinalis

Melilotus officinalis, or yellow sweet clover, contains coumarin and its derivative melilotoside as primary bioactives that support venous tone and lymphatic drainage. These compounds act on lymphangion contractility and capillary permeability to reduce edema and leg heaviness associated with chronic venous insufficiency.

Category: European Evidence: 2/10 Tier: Traditional

Melilotus officinalis — Hermetica Encyclopedia

Origin & History

Melilotus officinalis (sweet clover) is a perennial herb from the Fabaceae family, native to Europe, western Asia, and northern Africa, now found worldwide. The medicinal preparation uses dried above-ground parts harvested during flowering, processed into comminuted herb, powder, or extracts using ethanol or rapeseed oil. Upon drying, the plant's meliloside converts to coumarins, creating the active compounds.

Historical & Cultural Context

Melilotus has been used in European traditional medicine for over 30 years (documented 15+ years in EU) primarily for mild venous circulatory disturbances and skin inflammations. Historical documentation includes Commission E monographs, ESCOP recommendations, and inclusion in French and German medicinal plant lists for treating leg heaviness and swelling.

Health Benefits

• Supports venous circulation and reduces leg heaviness based on traditional use (EMA traditional use classification, no RCTs available)
• May help with mild skin inflammation when applied topically (traditional use only, no clinical trials)
• Potentially improves microcirculation through coumarin content (mechanism suggested but not clinically proven)
• Traditional use for reducing leg swelling associated with minor venous insufficiency (30+ years traditional use documented)
• May provide mild anti-inflammatory effects through prostaglandin synthesis inhibition (proposed mechanism, no human studies)

How It Works

Coumarin (1,2-benzopyrone) derived from melilotoside in Melilotus officinalis stimulates macrophage-mediated proteolysis of accumulated interstitial proteins, reducing high-protein edema and improving lymphatic flow. Coumarin also inhibits phosphodiesterase activity, raising intracellular cAMP levels in endothelial cells, which decreases capillary hyperpermeability and strengthens vascular wall integrity. Additionally, flavonoids such as kaempferol and quercetin present in the plant exert antioxidant and anti-inflammatory effects by inhibiting NF-κB signaling and reducing prostaglandin synthesis via COX pathway modulation.

Scientific Research

The EMA/HMPC assessment found no clinical trials or RCTs evaluating Melilotus officinalis efficacy, with all indications based solely on traditional use for at least 30 years (15 years in EU). Searches for human studies from 1900 onward yielded limited data, with evidence relying on historical literature from ESCOP, Commission E, and national formularies rather than modern clinical trials.

Clinical Summary

Clinical evidence for Melilotus officinalis relies primarily on EMA traditional-use classification rather than modern RCTs. Constituent-level studies on coumarin by Casley-Smith involving up to 100 lymphedema patients demonstrated 30–40% limb volume reductions, but these findings carry methodological limitations. No large-scale, placebo-controlled trials on the standardized herb extract exist to date. Evidence is therefore considered Grade C — supporting traditional use but insufficient for confirmed therapeutic claims under modern standards.

Nutritional Profile

Melilotus officinalis (yellow sweet clover) is a medicinal herb rather than a dietary staple; nutritional macronutrient data is limited but the following bioactive and nutritional constituents are documented: Coumarins: primary bioactive class, with coumarin (benzopyrone) at approximately 0.4–0.9% dry weight in flowering tops, alongside melilotin and melilotosides as precursor glycosides. Flavonoids: quercetin, kaempferol, and luteolin glycosides present at approximately 0.5–1.2% dry weight, contributing antioxidant activity. Saponins: oleanolic acid and related triterpenoid saponins at approximately 0.3–0.8% dry weight. Hydroxycinnamic acids: caffeic acid and chlorogenic acid detected at trace to low concentrations (estimated 0.1–0.3% dry weight). Volatile oils: minor fraction (<0.1%), containing coumaraldehyde and related aromatic compounds responsible for characteristic vanilla-like scent. Protein content: approximately 15–20% dry weight in whole plant biomass typical of legume family members, though medicinal preparations use aerial flowering parts where protein contribution is lower (~8–12% dry weight). Fiber: crude fiber approximately 20–28% dry weight in dried herb material. Minerals: moderate calcium (~1,200–1,500 mg/100g dry weight), potassium (~1,000–1,400 mg/100g dry weight), magnesium (~200–300 mg/100g dry weight), and iron (~15–25 mg/100g dry weight), consistent with leguminous herbs. Vitamins: vitamin C reported at low concentrations (~20–40 mg/100g fresh weight); vitamin K presence is pharmacologically relevant given coumarin content and potential anticoagulant interactions. Bioavailability notes: coumarin glycosides require enzymatic hydrolysis in the gut for activation; oral bioavailability of free coumarin is moderate (~72% absorbed in humans per pharmacokinetic studies); flavonoid bioavailability is limited by conjugation and first-pass metabolism; topical preparations bypass hepatic first-pass effects, supporting dermal applications. Standardized extracts typically normalized to 0.2–0.4% coumarin content per EMA monograph specifications.

Preparation & Dosage

Traditional use dosages (not clinically studied): Dry herb 2-4 g/day as infusion (0.25-1 g single dose); Liquid extract (30-65% ethanol) 2-4 ml/day; Semi-solid extract in rapeseed oil for external use only. No standardized doses based on coumarin content have been established through clinical research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Horse chestnut, butcher's broom, gotu kola, vitamin C, bioflavonoids

Safety & Interactions

Melilotus officinalis contains coumarin compounds that can be converted to dicoumarol by fungal contamination of improperly stored plant material, posing a clinically significant risk of anticoagulation and bleeding — it should never be used with warfarin, heparin, or other anticoagulant/antiplatelet drugs. Isolated coumarin at high doses has been associated with hepatotoxicity in sensitive individuals, so standardized preparations should be used at EMA-recommended doses (herb equivalent providing no more than 1 mg coumarin per day for oral use). The plant is contraindicated in pregnancy and lactation due to insufficient safety data, and in individuals with known liver disease or coagulation disorders. Common mild side effects include gastrointestinal upset and headache; allergic reactions are rare but possible in individuals sensitive to Fabaceae family plants.